EP Patent

EP3984536B1 — Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Assigned to Centre National de la Recherche Scientifique CNRS · Expires 2025-06-25 · 1y expired

What this patent protects

Patent listed against Vitekta.

Drugs covered by this patent

Patent Metadata

Patent number
EP3984536B1
Jurisdiction
EP
Classification
—
Expires
2025-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Centre National de la Recherche Scientifique CNRS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.